VJHemOnc is committed to improving our service to you

IMW 2019 | Daratumumab consolidation therapy in MM

VJHemOnc is committed to improving our service to you

Alessandro Gozzetti

Alessandro Gozzetti, MD, PhD, Sense University Hospital, Siena, Italy, discusses the use of daratumumab as consolidation therapy, in particular after autologous STEM cell transplantation in multiple myeloma (MM) patients, speaking at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter